about
Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritisA European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical PharmacogenomicsY-chromosome phylogeographic analysis of the Greek-Cypriot population reveals elements consistent with Neolithic and Bronze Age settlementsCNVs-microRNAs interactions demonstrate unique characteristics in the human genome. An interspecies in silico analysisA miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathyMolecular investigation of distal renal tubular acidosis in Tunisia, evidence for founder mutationsEpistatic role of the MYH9/APOL1 region on familial hematuria genes.Frequency of COL4A3/COL4A4 mutations amongst families segregating glomerular microscopic hematuria and evidence for activation of the unfolded protein response. Focal and segmental glomerulosclerosis is a frequent development during ageingScreening for mutations in kidney-related genes using SURVEYOR nuclease for cleavage at heteroduplex mismatches.Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigreesGenetic polymorphisms in warfarin and tacrolimus-related genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot population.Homo sapiens exhibit a distinct pattern of CNV genes regulation: an important role of miRNAs and SNPs in expression plasticityThe role of molecular genetics in diagnosing familial hematuria(s).A functional variant in NEPH3 gene confers high risk of renal failure in primary hematuric glomerulopathies. Evidence for predisposition to microalbuminuria in the general population.X-linked, COL4A5 hypomorphic Alport mutations such as G624D and P628L may only exhibit thin basement membrane nephropathy with microhematuria and late onset kidney failure.C3 glomerulonephritis/CFHR5 nephropathy is an endemic disease in Cyprus: clinical and molecular findings in 21 families.Molecular genetics of familial hematuric diseases.Evidence for activation of the unfolded protein response in collagen IV nephropathiesPlasticity vs Mutation. The role of microRNAs in human adaptation.A novel splice-site mutation in ATP6V0A4 gene in two brothers with distal renal tubular acidosis from a consanguineous Tunisian family.Residual renal function in hemodialysis patients: the role of Angiotensin-converting enzyme inhibitor in its preservation.Molecular and Clinical Investigation of Cystinuria in the Greek-Cypriot Population.Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.Evidence for contribution of the y chromosome in atherosclerotic plaque occurrence in men.X-linked Alport syndrome in Hellenic families: phenotypic heterogeneity and mutations near interruptions of the collagen domain in COL4A5.Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidnGenetic epidemiology of cancer predisposition DNA repair genes is probably related with ancestral surviving under adverse environmental conditions.COL4A3 founder mutations in Greek-Cypriot families with thin basement membrane nephropathy and focal segmental glomerulosclerosis dating from around 18th century.Combination of 247 genome-wide association studies reveals high cancer risk as a result of evolutionary adaptation.Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.Ischemic but not mechanical preconditioning attenuates ischemia/reperfusion induced myocardial apoptosis in anaesthetized rabbits: the role of Bcl-2 family proteins and ERK1/2.Distal renal tubular acidosis in a Libyan patient: Evidence for digenic inheritance.Carriers of Autosomal Recessive Alport Syndrome with Thin Basement Membrane Nephropathy Presenting as Focal Segmental Glomerulosclerosis in Later Life.Co-Inheritance of Functional Podocin Variants with Heterozygous Collagen IV Mutations Predisposes to Renal Failure.Y chromosome and cardiovascular risk: What are we missing?Founder mutations in the ATP6V1B1 gene explain most Cypriot cases of distal renal tubular acidosis: first prenatal diagnosis.COL4A5 and LAMA5 variants co-inherited in familial hematuria: digenic inheritance or genetic modifier effect?Influenza Virus-Host Co-evolution. A Predator-Prey Relationship?Evidence that NPHS2-R229Q predisposes to proteinuria and renal failure in familial hematuriaIncreased Number of MicroRNA Target Sites in Genes Encoded in CNV Regions. Evidence for an Evolutionary Genomic Interaction
P50
Q24615589-6AC76611-8A4A-43C3-91E7-5C27EFF557DFQ28554199-8C82282C-9D7F-492D-B02D-4E342485BCA6Q28600966-83A04C8D-6742-4540-AAE2-ABB73647C732Q28661378-FA2CCB35-7D87-40DD-8401-B7FE07A97010Q34154720-59696B5E-C70D-4DE5-A5F8-68EC1D664FFAQ34440012-9D358D0F-2703-4226-9070-C1436C060B07Q34629400-76921CED-5131-4F5A-A053-4B4A275F9FF7Q34712797-74A2C5D5-FAA4-4FC7-9E57-190A1FCD3F20Q34986719-2CF74FAA-F92A-49E3-A4B5-A3A3AA211036Q35030648-4C95CFA7-4D4A-496C-A5A9-988D8A09E5FCQ35110430-7C0B08CB-C35F-4A5A-B1E7-F1D4F94E0F0DQ35856472-2ECB694B-EEDB-4A6C-9CD9-DAD44A16AE8AQ36056811-108986EB-58A1-42B7-9D6F-674626B1EC20Q36319999-89CC348B-A1C4-4FCF-ADEA-0AD4A74660C3Q37413366-91248D20-E236-41C9-A594-9F1785B8930CQ38080871-D6C1A730-4061-4759-B8ED-C35F1E8FEA22Q38138908-FDBFC821-EC14-48E9-87D1-74B7AD530422Q38311017-B0116870-FC11-47F3-984A-EF6325E3EFB6Q39069009-245BA2BF-8973-4058-85B8-2F30B1A759C9Q39290098-402FC01B-CA5F-4189-A0E9-A67A61EB8867Q40304689-E78706B7-5445-4B57-A8E9-3912435316D4Q40352212-D6458103-6ED1-4F30-975D-34D1BF7A25DDQ42320992-0B3567FC-932E-4255-BDF9-1D9DF5AC7D01Q43416900-DEC2A7D7-8687-4E15-8858-7BA57CB33FD2Q43457773-D37AAC3F-D111-4EE4-A119-08D9072D6DFFQ43856240-583D722F-CD4C-4FD8-BC10-F06017533CBDQ47216832-11B2A785-26BC-437B-9874-A49A6778BE31Q47281958-BC7E7069-5F90-48F9-9B93-69BD8978E045Q47343132-5703CD50-26B8-4B11-AAFB-7FB3C41956F6Q48249735-266AE971-4319-4462-8C1C-8589D092EEB5Q48651631-4B848F4D-EA7D-4BAB-BA2F-96C6D8E3A4E3Q50099715-60AD9604-2037-40D3-88EB-860A37453D46Q53413309-753F8C3C-769D-45CC-8736-70EA12D44C74Q53442615-FBDE3A13-9A51-4A42-8EB2-C235BB87F3E3Q53758168-BF59DD61-2110-4D49-A133-26C99DD3988AQ54652859-32A909A2-BC45-4D07-B9D9-CEB9734EE5DCQ55346878-426836D8-BDD8-4B21-80C7-17717FC105A4Q56998080-0B2CE745-580D-4C6F-9D60-6F9E70FC0FD0Q59416400-EB58A813-EE7D-4A45-8FC5-45285C520A40Q59416407-44193B4E-BF55-4CC9-9154-68F7E16F2363
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Konstantinos Voskarides
@en
Konstantinos Voskarides
@es
Konstantinos Voskarides
@nl
Konstantinos Voskarides
@sl
type
label
Konstantinos Voskarides
@en
Konstantinos Voskarides
@es
Konstantinos Voskarides
@nl
Konstantinos Voskarides
@sl
prefLabel
Konstantinos Voskarides
@en
Konstantinos Voskarides
@es
Konstantinos Voskarides
@nl
Konstantinos Voskarides
@sl
P106
P1153
22956261200
P31
P496
0000-0002-3705-3451